EDWARD C TRAVIS

Allopathic & Osteopathic Physicians|Family Medicine DU QUOIN, IL NPI 1801909700

General Payments — all program years on this page

$1,025.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 64
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $204.73 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $204.7312

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $70.255
Novo Nordisk AS $22.151
Grifols USA, LLC $21.251
Lilly USA, LLC $20.441
ABBVIE INC. $19.001
ITI, Inc. $18.661
PFIZER INC. $17.891
Mylan Specialty L.P. $15.091

By program year

Program yearAmountRecords
2018 $48.443
2019 $169.0911
2020 $24.322
2021 $156.9011
2022 $242.3615
2023 $179.9910
2024 $204.7312

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097272672 Novo Nordisk Inc $22.15 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104522780 AstraZeneca Pharmaceuticals LP $13.96 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104606188 AstraZeneca Pharmaceuticals LP $14.71 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105530066 AstraZeneca Pharmaceuticals LP $13.48 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105595819 AstraZeneca Pharmaceuticals LP $14.05 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105703448 AstraZeneca Pharmaceuticals LP $14.05 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106241300 ABBVIE INC. $19.00 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124752651 Grifols USA, LLC $21.25 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132016467 PFIZER INC. $17.89 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134966899 Lilly USA, LLC $20.44 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143334458 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.66 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147290482 Mylan Specialty L.P. $15.09 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.